Moreover, with the progression of lung cancer, the high expression of IL-10 in TAMs in NSCLC is associated with poor overall survival, and the expression of IL-10 in lung cancer cells is not changed (94), indicating that IL-10 secreted by TAMs during cancer progression is the key to promote cancer progression. This evidence concerns the gene IL10 and lung carcinoma.